Lipid Metabolism and Cardiovascular Risk in HIV-1 Infection and HAART: Present and Future Problems
Figure 1
Incidence rates of myocardial infarction according to cumulative exposure to nucleoside/nucleotide analogues (A–G), protease inhibitors (H–K), and nonnucleoside reverse transcriptase inhibitors (L, M). The grey areas indicate the 95% confidence interval. PYFU, person-years of followup. Adapted from Worm et al. [24].
